Filing Details

Accession Number:
0001062993-25-001617
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-04 16:11:53
Reporting Period:
2025-01-31
Accepted Time:
2025-02-04 16:11:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1455365 Cognition Therapeutics Inc CGTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1418200 Lisa Ricciardi C/O Cognition Therapeutics Inc
2500 Westchester Avenue
Purchase NY 10577
Ceo & President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-01-31 38,851 $0.77 38,851 No 4 P Indirect By Spouse
Common Stock Disposition 2025-02-03 28,960 $0.67 262,385 No 4 F Direct
Common Stock Acquisiton 2025-02-04 631,300 $0.00 893,685 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Spouse
No 4 F Direct
No 4 A Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.7602 to $0.7816, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
  3. Each share is represented by an RSU. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.